Population-based Study in Screening for Liver Fibrosis

CompletedOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

November 7, 2024

Study Completion Date

January 7, 2025

Conditions
Liver Diseases
Trial Locations (45)

1000

Poliklinika Croatia, Zagreb

10000

Dubrava Hospital, Zagreb

92230

Centre de santé Municipal Etienne Gatineau-Sailliant de Genevilliers, Gennevilliers

Unknown

Odense University Hospital, Odense

Centre de Recherche Clinique - CRC, Paris

Hospital Avicenne, Paris

Hospital Beaujon, Paris

Homburg Hospital, Homburg

Altstadtpraxis, Mainz

Mainz Hospital, Mainz

Praxis Mombach, Mainz

MVZ Dres.Schneider Kaiserslautern, Rodenbach

Medicina Di gruppo di montagnana, Padua

Vigonza Medica, Padua

Medical Center Rotterdam, Rotterdam

F. D. Roosevelt Univ. Hospital, Banská Bystrica

Hospital Germans Trias i Pujol, Badalona

CAP II El Maresme, Mataró

CAP II Santa Coloma de Gramanet, Santa Coloma de Gramenet

CAP La Florida, Santa Perpètua de Mogoda

CAP Adrià, Barcelona

CAP Besos, Barcelona

CAP La Marina, Barcelona

CAP Numància, Barcelona

CAP Vila de Gracia, Barcelona

CAP Vila Olimpica, Barcelona

Hospital Gregorio Marañon, Madrid

CAP La Llantia, Mataró

James Wigg, London

Mild May, London

Oakleigh park, London

St Andrews Medical Practice, London

08760

SEAT, Martorell

08003

CAP Barceloneta, Barcelona

Hospital del Mar, Barcelona

08014

CAP Bordeta-Magòria, Barcelona

08016

CAP Río de Janeiro, Barcelona

08033

CAP Ciutat Meridiana, Barcelona

08035

CAP Sant Rafael, Barcelona

Hospital Universirati Vall d'Hebrón, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

HA8 0AP

Oak Lodge Medical Centre, Edgware

NW3 2QG

Royal Free Hospital, London

NG5 1PB

Nottingham University Hospital, Nottingham

NG17 4JL

King's Mill Hospital, Sutton in Ashfield

All Listed Sponsors
lead

Judit Pich Martínez

OTHER

NCT03789825 - Population-based Study in Screening for Liver Fibrosis | Biotech Hunter | Biotech Hunter